Clinical trial to evaluate minimally invasive procedure for women with pelvic venous disease

A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease (PeVD).

Innovent and ASK Pharm partner to commercialise limertinib

Limertinib is intended for the treatment of patients with lung cancer. Credit: New Africa/Shutterstock. Innovent Biologics and Jiangsu Aosaikang Pharmaceutical (ASK Pharm) have signed a

October 8, 2024

Optimi Health Granted Amendment to Dealer’s Licence by Health Canada to Supply Special Access Program | Psychedelic Finance

VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation

September 7, 2023

Lawmakers, as part of ‘lab leak’ Covid inquiry, press to bar EcoHealth from federal research funds

WASHINGTON — A House panel is pushing for a virus research group and its director to be barred from any federal funds and criminally investigated,

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.